1. Home
  2. SEPN vs CMCO Comparison

SEPN vs CMCO Comparison

Compare SEPN & CMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • CMCO
  • Stock Information
  • Founded
  • SEPN 2022
  • CMCO 1875
  • Country
  • SEPN United States
  • CMCO United States
  • Employees
  • SEPN N/A
  • CMCO N/A
  • Industry
  • SEPN
  • CMCO Construction/Ag Equipment/Trucks
  • Sector
  • SEPN
  • CMCO Industrials
  • Exchange
  • SEPN NYSE
  • CMCO Nasdaq
  • Market Cap
  • SEPN 453.2M
  • CMCO 472.4M
  • IPO Year
  • SEPN 2024
  • CMCO 1996
  • Fundamental
  • Price
  • SEPN $11.76
  • CMCO $16.26
  • Analyst Decision
  • SEPN Strong Buy
  • CMCO Hold
  • Analyst Count
  • SEPN 5
  • CMCO 1
  • Target Price
  • SEPN $26.75
  • CMCO $35.00
  • AVG Volume (30 Days)
  • SEPN 443.6K
  • CMCO 336.7K
  • Earning Date
  • SEPN 08-15-2025
  • CMCO 07-30-2025
  • Dividend Yield
  • SEPN N/A
  • CMCO 1.73%
  • EPS Growth
  • SEPN N/A
  • CMCO N/A
  • EPS
  • SEPN N/A
  • CMCO N/A
  • Revenue
  • SEPN $977,000.00
  • CMCO $963,027,000.00
  • Revenue This Year
  • SEPN N/A
  • CMCO $10.17
  • Revenue Next Year
  • SEPN $526.96
  • CMCO $33.08
  • P/E Ratio
  • SEPN N/A
  • CMCO N/A
  • Revenue Growth
  • SEPN 108.76
  • CMCO N/A
  • 52 Week Low
  • SEPN $4.17
  • CMCO $11.78
  • 52 Week High
  • SEPN $28.99
  • CMCO $41.05
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • CMCO 59.03
  • Support Level
  • SEPN N/A
  • CMCO $15.55
  • Resistance Level
  • SEPN N/A
  • CMCO $16.62
  • Average True Range (ATR)
  • SEPN 0.00
  • CMCO 0.64
  • MACD
  • SEPN 0.00
  • CMCO 0.18
  • Stochastic Oscillator
  • SEPN 0.00
  • CMCO 90.05

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

Share on Social Networks: